Mark Enyedy is an accomplished executive with extensive leadership experience in the pharmaceutical and biotechnology industries. Currently serving as an Independent Director at BioMarin Pharmaceutical Inc. and a Non Executive Director at ERGOMED, Mark previously held the position of President and Chief Executive Officer at ImmunoGen, Inc. from May 2016 to February 2024. Prior roles include Executive Vice President and Head of Corporate Development at Shire Pharmaceuticals and CEO at Proteostasis Therapeutics, Inc. Mark's foundational career was at Genzyme, where significant contributions were made as President for multiple therapeutic areas. Mark Enyedy earned a Doctor of Law (JD) degree from Harvard Law School between 1987 and 1990.
This person is not in the org chart
This person is not in any teams
This person is not in any offices